(BTW, the tests can have detailed descriptions so that you can document the exact steps needed to run that particular test.) Once a full run-through is complete, you can easily see how many tests were passed for that app and how many failed. It also lets you run through all the tests for a given app in test mode and mark each test as passing or failing. And when you create a new app, you can easily copy/duplicate tests from an existing app to fill the test cases for the new app. Currently, ESTRO-PROS Teaching Courses are organized addressing radiation oncologists worldwide.QArc allows you to keep all the QA tests you run on your apps in one single place. Since 2004 educational programmes have been created for the now independent countries of the former Soviet Union in collaboration with the International Atomic Energy Agency (IAEA) and the European Society of Therapeutic Radiation Oncology (ESTRO).
The activities also included prospective trials of SIOP (International Society for Paediatric Oncology) for medulloblastoma and intracranial germ cell tumours. With the introduction of prospective brain tumour trials in Germany in the early 90s prospective quality control programmes for radiotherapy were introduced on a nationwide level. The scientific expertise comprises quality control in radiation oncology with special emphasis on geometric precision of different radiotherapy technologies including craniospinal irradiation.Īfter qualification for radiation oncology in 1992, scientific research focused mainly on childhood brain tumours finally leading to the establishment of the German Study and Reference Centre for Paediatric Radiation Oncology in Childhood Brain Tumours. Kortmann was trained in radiology and radiooncology at the Department of Radiology and the Department of Radiooncology in Stuttgart, Essen and Tuebingen, Germany. Rolf-Dieter Kortmann is a Professor in Medicine and Head of Department of Radiation Therapy, University of Leipzig, Germany.ĭr. The world’s first proton therapy center dedicated solely to the treatment of pediatric cancer patients.ĭr. Jude Red Frog Events Proton Therapy Center. His special interests include brain tumors in young children, side effects of radiation therapy, re-irradiation, and proton therapy. The focus of his practice and research includes the following diseases: medulloblastoma, ependymoma, craniopharyngioma, and low-grade glioma. Merchant oversees a department that includes nearly 70 faculty and staff dedicated to pediatric radiation oncology. in experimental pathology from the University of Utrecht, The Netherlands. Merchant is board certified in Radiation Oncology and received his medical degree from the Chicago College of Osteopathic Medicine, Chicago, Illinois and Ph.D.
Rashid Endowed Chair in Radiation Oncology, and former chairman of the Radiation Oncology Discipline, Children’s Oncology Group (COG).ĭr. Jude Children’s Research Hospital in Memphis, Tennessee, Baddia J. Merchant is Chair of Radiation Oncology at St. The book concludes by examining future directions in the field.ĭr.
Beyond clinical radiation oncology, relevant information is provided on radiation physics.
Separate chapters address localization and verification procedures and anesthesia pediatric radiation oncology in the palliative care setting and aspects that are especially relevant in low- and medium-income countries. The use of image-guided and intensity-modulated radiation therapy is clearly described, and careful attention is also devoted to the roles of proton therapy, stereotactic radiosurgery, stereotactic fractionated radiosurgery, and modulated arc radiotherapy. Written by global experts in pediatric radiation oncology, it documents in detail the treatment regimens appropriate to each disease, highlighting the recent advances that promise to improve rates of survival and cure. This book presents the most up-to-date and innovative information on the targeting and treatment of a wide range of childhood cancers by means of radiation therapy.